Lexicon Pharmaceuticals, Inc. Share Price
Equities
LXRX
US5288723027
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +2.60% | -4.24% | +3.27% |
22/04 | Transcript : Lexicon Pharmaceuticals, Inc. - Analyst/Investor Day | |
25/03 | Lexicon Pharmaceuticals Files Prospectus for Secondary Offering | MT |
Sales 2024 * | 25.81M 2.15B | Sales 2025 * | 77.52M 6.46B | Capitalization | 389M 32.44B |
---|---|---|---|---|---|
Net income 2024 * | -199M -16.59B | Net income 2025 * | -193M -16.09B | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.02 x |
P/E ratio 2024 * |
-2.22
x | P/E ratio 2025 * |
-2.49
x | Employees | 285 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.99% |
Latest transcript on Lexicon Pharmaceuticals, Inc.
1 day | +2.60% | ||
1 week | -4.24% | ||
Current month | -34.17% | ||
1 month | -34.17% | ||
3 months | -13.19% | ||
6 months | +42.34% | ||
Current year | +3.27% |
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/14/07 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01/99/01 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/21/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01/01/01 |
Ray Debbane
CHM | Chairman | 69 | 01/07/01 |
Director/Board Member | 65 | 28/07/28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.58 | +2.60% | 1,271,998 |
25/24/25 | 1.54 | -3.75% | 1,686,207 |
24/24/24 | 1.6 | -0.62% | 1,763,310 |
23/24/23 | 1.61 | -5.85% | 3,561,170 |
22/24/22 | 1.71 | +3.64% | 4,093,358 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.27% | 389M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LXRX Stock